Drugs / ACM-1
last change Jun 2016 re-read 3 minutes ago

ACM-1

Developed for
ocular vascular disorder
Investigated by
Sun Yat-sen University

Trials 1

2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 0 NCT02448732 Dec 2014 → Apr 2016 ocular vascular disorder Sun Yat-sen University Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as ACM-1 ClinicalTrials.gov intervention name — accepted as the source's own label NCT02448732 ↗
Route Intravitreal “intravitreal injection with 50ul ACM-1 at a concentration of 1600ug/ml” NCT02448732 ↗